Urigen Pharmaceuticals is a leading pharmaceutical company based in Bound Brook, NJ, specializing in the development and commercialization of innovative products for urological indications.
With a focus on treating interstitial cystitis/bladder pain syndrome (IC/BPS), Urigen Pharmaceuticals is dedicated to providing effective clinical solutions and improving the quality of life for patients suffering from urological conditions.
Generated from the website